These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 18592835)

  • 41. Effective treatment of therapy-resistant chronic spontaneous urticaria with omalizumab.
    Magerl M; Staubach P; Altrichter S; Ardelean E; Krause K; Metz M; Weller K; Maurer M
    J Allergy Clin Immunol; 2010 Sep; 126(3):665-6. PubMed ID: 20673981
    [No Abstract]   [Full Text] [Related]  

  • 42. Dermatologic uses of omalizumabtitle.
    Chia JC; Mydlarski PR
    J Dermatolog Treat; 2017 Jun; 28(4):332-337. PubMed ID: 27759482
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Updates on urticaria].
    Boulinguez S
    Ann Dermatol Venereol; 2010 May; 137(5 Suppl 1):16-7. PubMed ID: 20510175
    [No Abstract]   [Full Text] [Related]  

  • 44. [Omalizumab for therapy-resistant chronic urticaria with angioedema].
    Korkmaz H; Eigelshoven S; Homey B
    Hautarzt; 2010 Oct; 61(10):828-31. PubMed ID: 20842328
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Thyroid autoimmunity in chronic urticaria.
    O'Donnell BF; Francis DM; Swana GT; Seed PT; Kobza Black A; Greaves MW
    Br J Dermatol; 2005 Aug; 153(2):331-5. PubMed ID: 16086744
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Omalizumab is effective in nonautoimmune urticaria.
    Ferrer M; Gamboa P; Sanz ML; Goikoetxea MJ; Cabrera-Freitag P; Javaloyes G; Berroa F; Kaplan AP
    J Allergy Clin Immunol; 2011 May; 127(5):1300-2. PubMed ID: 21315432
    [No Abstract]   [Full Text] [Related]  

  • 47. Development of angio-oedema after omalizumab injections in a patient with chronic spontaneous urticaria.
    Magen E; Chikovani T
    Clin Exp Dermatol; 2018 Oct; 43(7):825. PubMed ID: 29777532
    [No Abstract]   [Full Text] [Related]  

  • 48. Clinical utility of testing for autoimmunity in chronic idiopathic urticaria.
    Lapolla W; Desai N; English JC
    J Am Acad Dermatol; 2012 Mar; 66(3):e83-8. PubMed ID: 21565421
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Spontaneous (Autoimmune) Chronic Urticaria in Children: Current Evidences, Diagnostic Pitfalls and Therapeutic Management.
    Poddighe D; De Amici M; Marseglia GL
    Recent Pat Inflamm Allergy Drug Discov; 2016; 10(1):34-39. PubMed ID: 26899967
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mechanisms of autoimmune activation of basophils in chronic urticaria.
    Kikuchi Y; Kaplan AP
    J Allergy Clin Immunol; 2001 Jun; 107(6):1056-62. PubMed ID: 11398085
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Successful treatment of cholinergic urticaria with anti-immunoglobulin E therapy.
    Metz M; Bergmann P; Zuberbier T; Maurer M
    Allergy; 2008 Feb; 63(2):247-9. PubMed ID: 18186820
    [No Abstract]   [Full Text] [Related]  

  • 52. Serum autoreactivity predicts time to response to omalizumab therapy in chronic spontaneous urticaria.
    Gericke J; Metz M; Ohanyan T; Weller K; Altrichter S; Skov PS; Falkencrone S; Brand J; Kromminga A; Hawro T; Church MK; Maurer M
    J Allergy Clin Immunol; 2017 Mar; 139(3):1059-1061.e1. PubMed ID: 27838346
    [No Abstract]   [Full Text] [Related]  

  • 53. Allergic skin diseases.
    Fox RW
    J Fla Med Assoc; 1996; 83(6):394-7. PubMed ID: 8752365
    [No Abstract]   [Full Text] [Related]  

  • 54. Anti-immunoglobulin E treatment of patients with recalcitrant physical urticaria.
    Metz M; Altrichter S; Ardelean E; Kessler B; Krause K; Magerl M; Siebenhaar F; Weller K; Zuberbier T; Maurer M
    Int Arch Allergy Immunol; 2011; 154(2):177-80. PubMed ID: 20733327
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Recurrent angioedema and urticaria.
    Bishop PC; Wisnieski JJ; Christensen J
    West J Med; 1993 Nov; 159(5):605-8. PubMed ID: 8279170
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Successful treatment of autoimmune chronic idiopathic urticaria with intravenous cyclophosphamide.
    Bernstein JA; Garramone SM; Lower EG
    Ann Allergy Asthma Immunol; 2002 Aug; 89(2):212-4. PubMed ID: 12197581
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Thyroid autoantibodies in autoimmune diseases.
    Innocencio RM; Romaldini JH; Ward LS
    Medicina (B Aires); 2004; 64(3):227-30. PubMed ID: 15239536
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Positive impact of omalizumab on angioedema and quality of life in patients with refractory chronic idiopathic/spontaneous urticaria: analyses according to the presence or absence of angioedema.
    Maurer M; Sofen H; Ortiz B; Kianifard F; Gabriel S; Bernstein JA
    J Eur Acad Dermatol Venereol; 2017 Jun; 31(6):1056-1063. PubMed ID: 27911016
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Severe angioedema and urticaria related to thyroid antigenicity.
    Raza SA; Salam Z; Blank RD; Jaume J; Drezner MK
    Endocr Pract; 2004; 10(5):445-7. PubMed ID: 15760794
    [No Abstract]   [Full Text] [Related]  

  • 60. Chronic urticaria and thyroid auto-immunity.
    Palma-Carlos AG; Palma-Carlos ML
    Eur Ann Allergy Clin Immunol; 2005 Apr; 37(4):143-6. PubMed ID: 15916015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.